117 related articles for article (PubMed ID: 28268072)
1. Pharmacist-led interventions for the management of medication misuse and abuse: A systematic review.
Baum L; Badejo G; Chaboyer K; Leong C
J Am Pharm Assoc (2003); 2017; 57(3):297-298. PubMed ID: 28268072
[No Abstract] [Full Text] [Related]
2. Pharmacist utilization of prescription opioid misuse interventions: Acceptability among pharmacists and patients.
Riley TB; Alemagno S
Res Social Adm Pharm; 2019 Aug; 15(8):986-991. PubMed ID: 30665825
[TBL] [Abstract][Full Text] [Related]
3. Prescription drug abuse communication: A qualitative analysis of prescriber and pharmacist perceptions and behaviors.
Hagemeier NE; Tudiver F; Brewster S; Hagy EJ; Hagaman A; Pack RP
Res Social Adm Pharm; 2016; 12(6):937-948. PubMed ID: 26806859
[TBL] [Abstract][Full Text] [Related]
4. [The Pharmacist as Gatekeeper of Prescription Drug Abuse: Return to "Community Scientists"].
Shimane T
Yakugaku Zasshi; 2016; 136(1):79-87. PubMed ID: 26725672
[TBL] [Abstract][Full Text] [Related]
5. Community pharmacy interventions to improve antibiotic stewardship and implications for pharmacy education: A narrative overview.
Bishop C; Yacoob Z; Knobloch MJ; Safdar N
Res Social Adm Pharm; 2019 Jun; 15(6):627-631. PubMed ID: 30279131
[TBL] [Abstract][Full Text] [Related]
6. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
Mandt I; Horn AM; Ekedahl A; Granas AG
Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
[TBL] [Abstract][Full Text] [Related]
7. A systematic review in select countries of the role of the pharmacist in consultations and sales of non-prescription medicines in community pharmacy.
van Eikenhorst L; Salema NE; Anderson C
Res Social Adm Pharm; 2017; 13(1):17-38. PubMed ID: 27033426
[TBL] [Abstract][Full Text] [Related]
8. Pharmacists Who Screen and Discuss Opioid Misuse With Patients: Future Directions for Research and Practice.
Cochran G; Field C; Lawson K
J Pharm Pract; 2015 Aug; 28(4):404-12. PubMed ID: 24532819
[TBL] [Abstract][Full Text] [Related]
9. The attitudes and practice strategies of community pharmacists towards drug misuse management: A scoping review.
Hoppe D; Ristevski E; Khalil H
J Clin Pharm Ther; 2020 Jun; 45(3):430-452. PubMed ID: 31873962
[TBL] [Abstract][Full Text] [Related]
10. Misuse of non-prescription codeine containing products: Recommendations for detection and reduction of risk in community pharmacies.
Van Hout MC; Norman I
Int J Drug Policy; 2016 Jan; 27():17-22. PubMed ID: 26454626
[TBL] [Abstract][Full Text] [Related]
11. Beyond equivalence of care in prison pharmacy.
Choudhry K; Evans N
Int J Pharm Pract; 2014 Oct; 22(5):363-5. PubMed ID: 24400788
[TBL] [Abstract][Full Text] [Related]
12. Community pharmacist management of discharge medication summaries in primary care.
Wilcock M; Bearman D
Drug Ther Bull; 2019 Dec; 57(12):179-180. PubMed ID: 31527148
[No Abstract] [Full Text] [Related]
13. Do no harm: the role of community pharmacists in regulating public access to prescription drugs in Saudi Arabia.
Bahnassi A
Int J Pharm Pract; 2016 Apr; 24(2):142-5. PubMed ID: 26383607
[TBL] [Abstract][Full Text] [Related]
14. The paradox of pharmacy: A profession's house divided.
Brown D
J Am Pharm Assoc (2003); 2012; 52(6):e139-43. PubMed ID: 23143300
[TBL] [Abstract][Full Text] [Related]
15. A review of countries' pharmacist-patient communication legal requirements on prescription medications and alignment with practice: Comparison of Nordic countries.
Svensberg K; Sporrong SK; Björnsdottir I
Res Social Adm Pharm; 2015; 11(6):784-802. PubMed ID: 25698364
[TBL] [Abstract][Full Text] [Related]
16. Assessing pharmacist-led annual wellness visits: Interventions made and patient and physician satisfaction.
Wilson CG; Park I; Sutherland SE; Ray L
J Am Pharm Assoc (2003); 2015; 55(4):449-54. PubMed ID: 26161489
[TBL] [Abstract][Full Text] [Related]
17. The General Practitioner-Pharmacist Collaboration (GPPC) study: a randomised controlled trial of clinical medication reviews in community pharmacy.
Bryant LJ; Coster G; Gamble GD; McCormick RN
Int J Pharm Pract; 2011 Apr; 19(2):94-105. PubMed ID: 21385240
[TBL] [Abstract][Full Text] [Related]
18. Pharmacist participation in health policy development.
Matzke GR
Am J Health Syst Pharm; 2016 Feb; 73(3):107. PubMed ID: 26796902
[No Abstract] [Full Text] [Related]
19. Knowledge of and readiness for medication therapy management among community pharmacists in Lebanon.
Domiati S; Sacre H; Lahoud N; Sili G; Salameh P
Int J Clin Pharm; 2018 Oct; 40(5):1165-1174. PubMed ID: 29858761
[TBL] [Abstract][Full Text] [Related]
20. Attitudes toward and factors affecting implementation of medication therapy management services by community pharmacists.
MacIntosh C; Weiser C; Wassimi A; Reddick J; Scovis N; Guy M; Boesen K
J Am Pharm Assoc (2003); 2009; 49(1):26-30. PubMed ID: 19196593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
